Evidence map›Paper›PMID 39589707›Full record

ArticleAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2025

Impact of Renal Function Estimation Formulae on Use and Correct Dosing of NOACs in Patients with Non-valvular Atrial Fibrillation in Real Life in Germany.

Uwe Zeymer, Thomas Riemer, Ulrich Wolf, Steffen Schaefer, Jens Taggeselle, Hans-Joachim Kabitz, Roland Prondzinsky, Tim Süselbeck, Thomas Kleemann, Ralf Zahn and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in American journal of cardiovascular drugs : drugs, devices, and other interventions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Uwe ZeymerKlinikum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063, Ludwigshafen, Germany. Uwe.Zeymer@t-online.de.
Thomas RiemerInstitut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany.
Ulrich WolfKardiologische Praxis, Stahnsdorf, Germany.
Steffen SchaeferKardiologische Praxis, Querfurth, Germany.
Jens TaggeselleKardiologische Praxis, Markkleeberg, Germany.
Hans-Joachim KabitzKantonsspital Aarau, Aarau, Switzerland.
Roland ProndzinskyCarl-Von-Basedow-Klinikum Merseburg, Merseburg, Germany.
Tim SüselbeckKardiologische Praxisklinik Ludwigshafen, Ludwigshafen, Germany.
Thomas KleemannKlinikum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063, Ludwigshafen, Germany.
Ralf ZahnKlinikum Ludwigshafen, Medizinische Klinik B, Bremserstrasse 79, 67063, Ludwigshafen, Germany.
Tobias HeerMünchen Klinik Neuperlach, Department of Cardiology, Academic Teaching Hospital of LMU University of Munich, Oskar-Maria-Graf-Ring 51, 81737, München, Germany.ORCID http://orcid.org/0000-0003-1547-9918
APAF-Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39589707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.